
The NMR-SCEJA2A-301A is a state-of-the-art metabolomics platform designed to assess the risk of chronic kidney disease (CKD) by analyzing lipid and metabolic biomarkers. This tool leverages nuclear magnetic resonance (NMR) spectroscopy to provide comprehensive insights into CKD risk, aiding in early detection and management.
Detailed engineering parameters based on manufacturer documentation